1889 Stock Overview
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacturing, marketing, and selling of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Sanai Health Industry Group Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.058 |
52 Week High | HK$0.12 |
52 Week Low | HK$0.051 |
Beta | 1.06 |
1 Month Change | -15.94% |
3 Month Change | -17.14% |
1 Year Change | -31.76% |
3 Year Change | n/a |
5 Year Change | -86.19% |
Change since IPO | -97.04% |
Recent News & Updates
Shareholder Returns
1889 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | -1.7% | 3.9% | -1.5% |
1Y | -31.8% | -4.1% | 3.0% |
Return vs Industry: 1889 underperformed the Hong Kong Pharmaceuticals industry which returned -4.1% over the past year.
Return vs Market: 1889 underperformed the Hong Kong Market which returned 3% over the past year.
Price Volatility
1889 volatility | |
---|---|
1889 Average Weekly Movement | 8.8% |
Pharmaceuticals Industry Average Movement | 5.8% |
Market Average Movement | 6.5% |
10% most volatile stocks in HK Market | 14.2% |
10% least volatile stocks in HK Market | 3.2% |
Stable Share Price: 1889 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: 1889's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 71 | n/a | https://www.1889hk.com |
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacturing, marketing, and selling of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company also engages in development, manufacturing, marketing, and sale of pharmaceutical products and pharmaceutical related software; and provision of consultancy services.
Sanai Health Industry Group Company Limited Fundamentals Summary
1889 fundamental statistics | |
---|---|
Market Cap | HK$182.98m |
Earnings (TTM) | HK$39.33m |
Revenue (TTM) | HK$194.17m |
4.7x
P/E Ratio1.0x
P/S RatioIs 1889 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1889 income statement (TTM) | |
---|---|
Revenue | CN¥181.13m |
Cost of Revenue | CN¥99.66m |
Gross Profit | CN¥81.47m |
Other Expenses | CN¥44.78m |
Earnings | CN¥36.69m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.011 |
Gross Margin | 44.98% |
Net Profit Margin | 20.26% |
Debt/Equity Ratio | 23.0% |
How did 1889 perform over the long term?
See historical performance and comparison